ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 106 filers reported holding ASCENDIS PHARMA A/S in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $306,874,386 | +9.2% | 3,277,172 | +4.1% | 0.06% | +15.1% |
| Q2 2023 | $281,039,327 | -10.7% | 3,148,900 | +7.3% | 0.05% | -14.5% |
| Q1 2023 | $314,561,178 | -15.7% | 2,933,792 | -3.9% | 0.06% | -17.3% |
| Q4 2022 | $372,936,779 | -1.7% | 3,053,605 | -16.8% | 0.08% | -7.4% |
| Q3 2022 | $379,194,000 | +14.9% | 3,672,226 | +3.5% | 0.08% | +22.7% |
| Q2 2022 | $329,927,000 | -39.7% | 3,549,137 | -23.9% | 0.07% | -29.8% |
| Q1 2022 | $547,552,000 | -0.0% | 4,665,579 | +14.6% | 0.09% | +6.8% |
| Q4 2021 | $547,635,000 | -12.9% | 4,070,724 | +3.2% | 0.09% | -17.8% |
| Q3 2021 | $628,832,000 | +39.2% | 3,945,244 | +14.9% | 0.11% | +42.7% |
| Q2 2021 | $451,780,000 | +0.4% | 3,434,273 | -1.7% | 0.08% | -5.1% |
| Q1 2021 | $450,093,000 | -20.7% | 3,492,333 | +2.7% | 0.08% | -24.0% |
| Q4 2020 | $567,313,000 | +13.1% | 3,401,558 | +4.6% | 0.10% | 0.0% |
| Q3 2020 | $501,813,000 | +89.9% | 3,251,761 | +82.0% | 0.10% | +76.3% |
| Q2 2020 | $264,192,000 | +40.5% | 1,786,291 | +7.0% | 0.06% | +18.0% |
| Q1 2020 | $188,075,000 | -21.3% | 1,670,146 | -2.7% | 0.05% | 0.0% |
| Q4 2019 | $238,916,000 | +212.4% | 1,717,335 | +116.3% | 0.05% | +194.1% |
| Q3 2019 | $76,484,000 | +455.6% | 794,066 | +564.3% | 0.02% | +466.7% |
| Q2 2019 | $13,765,000 | +6.7% | 119,539 | +9.1% | 0.00% | 0.0% |
| Q1 2019 | $12,897,000 | +322.7% | 109,577 | +125.0% | 0.00% | +200.0% |
| Q4 2018 | $3,051,000 | -0.4% | 48,698 | +12.6% | 0.00% | 0.0% |
| Q3 2018 | $3,063,000 | -22.4% | 43,231 | -27.1% | 0.00% | 0.0% |
| Q2 2018 | $3,947,000 | +244.1% | 59,321 | +238.3% | 0.00% | – |
| Q1 2018 | $1,147,000 | – | 17,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |